Schonfeld Strategic Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,501	Closed	-$361K	–	2271
2025 Q3	$361K	Buy	+2,501	New	+$341K	﹤0.01%	1790
2025 Q1	–	Sell	-3,789	Closed	-$501K	–	2330
2024 Q4	$501K	Buy	+3,789	New	+$533K	﹤0.01%	1393
2019 Q3	–	Sell	-10,854	Closed	-$1.18M	–	1117
2019 Q2	$1.18M	Buy	+10,854	New	+$1.15M	0.04%	404
2016 Q4	–	Sell	-14,400	Closed	-$1.39M	–	595
2016 Q3	$1.39M	Buy	+14,400	New	+$1.37M	0.24%	117
2016 Q2	–	Sell	-49,200	Closed	-$4.28M	–	475
2016 Q1	$4.28M	Buy	+49,200	New	+$4.4M	1.74%	6

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Schonfeld Strategic Advisors's IBB Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 2,501 shares — an estimated $361K sold.

Schonfeld Strategic Advisors first reported a position in IBB in Q1 2016 and held it in 5 quarters. The position peaked at $4.28M in Q1 2016. 958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

Schonfeld Strategic Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 2,501 iShares Biotechnology ETF shares in Q4 2025, an estimated $361K.
Schonfeld Strategic Advisors first reported a position in iShares Biotechnology ETF in Q1 2016 and held it in 5 quarters.
Schonfeld Strategic Advisors's iShares Biotechnology ETF position peaked at $4.28M in Q1 2016.
958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.